Recent changes
Track the most recent changes to the wiki on this page.
22 January 2020
| N 20:47 | User talk:Jwarner (diff | hist) . . (+116) . . Jwarner (talk | contribs) (Created page with "The page you'd need to edit for the banner is: https://hemonc.org/w/index.php?title=MediaWiki:Sitenotice&action=edit") |
| m 17:41 | Chronic lymphocytic leukemia (diff | hist) . . (+2,732) . . Jwarner (talk | contribs) |
| m 16:42 | Hepatocellular carcinoma (diff | hist) . . (-1) . . Jwarner (talk | contribs) (→Regimen {{#subobject:f3a095|Variant=1}}) |
| m 16:41 | HemOnc vocabulary concepts (6 changes | history) . . (+2,036) . . [Jwarner (6×)] | ||
| m | 16:41 (cur | prev) . . (+346) . . Jwarner (talk | contribs) (→Study-level concepts) | ||
| m | 16:36 (cur | prev) . . (+474) . . Jwarner (talk | contribs) (→Component-level concepts) | ||
| m | 13:55 (cur | prev) . . (+345) . . Jwarner (talk | contribs) (→Regimen-level concepts) | ||
| m | 13:30 (cur | prev) . . (+316) . . Jwarner (talk | contribs) (→Condition-level concepts) | ||
| m | 13:23 (cur | prev) . . (+37) . . Jwarner (talk | contribs) | ||
| m | 13:21 (cur | prev) . . (+518) . . Jwarner (talk | contribs) |
| m 12:45 | Regimen classes (2 changes | history) . . (+118) . . [Jwarner (2×)] | ||
| m | 12:45 (cur | prev) . . (+85) . . Jwarner (talk | contribs) (→Trastuzumab-based regimen) | ||
| m | 12:44 (cur | prev) . . (+33) . . Jwarner (talk | contribs) (→Endocrine-based regimen) |
| 12:24 | Myelodysplastic syndrome (11 changes | history) . . (+5,804) . . [Jwarner (11×)] | ||
| m | 12:24 (cur | prev) . . (+2,208) . . Jwarner (talk | contribs) | ||
| m | 12:17 (cur | prev) . . (+2,646) . . Jwarner (talk | contribs) (→Luspatercept monotherapy {{#subobject:8dgac1|Regimen=1}}) | ||
| m | 12:17 (cur | prev) . . (-2,621) . . Jwarner (talk | contribs) (→Placebo) | ||
| m | 12:16 (cur | prev) . . (+2,994) . . Jwarner (talk | contribs) (→Erythropoietin monotherapy {{#subobject:9uyac1|Regimen=1}}) | ||
| m | 12:15 (cur | prev) . . (-2,949) . . Jwarner (talk | contribs) (→Epoetin & Lenalidomide {{#subobject:495acc|Regimen=1}}) | ||
| m | 12:15 (cur | prev) . . (+7,531) . . Jwarner (talk | contribs) (→Luspatercept monotherapy {{#subobject:8dgac1|Regimen=1}}) | ||
| m | 12:14 (cur | prev) . . (-7,531) . . Jwarner (talk | contribs) (→Lenalidomide monotherapy {{#subobject:dfbcc0|Regimen=1}}) | ||
| 12:13 (cur | prev) . . (+1,476) . . Jwarner (talk | contribs) | |||
| m | 12:07 (cur | prev) . . (+211) . . Jwarner (talk | contribs) (→Guidelines) | ||
| m | 12:06 (cur | prev) . . (+80) . . Jwarner (talk | contribs) (→"How I treat") | ||
| 12:02 (cur | prev) . . (+1,759) . . Jwarner (talk | contribs) (→First-line therapy) |
| N 11:55 | Luspatercept (Reblozyl) (diff | hist) . . (+1,095) . . Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: A soluble, recombinant fusion protein composed of a modified form of the extracellular domain of human activin receptor t...") |
| m 11:53 | Epoetin alfa (Procrit) (diff | hist) . . (+75) . . Jwarner (talk | contribs) (→References) |
| m 11:31 | Drug index (diff | hist) . . (+4) . . Jwarner (talk | contribs) (→L) |
21 January 2020
| 22:13 | Follicular lymphoma (2 changes | history) . . (+3,574) . . [Jwarner; Alikhaki] | ||
| m | 22:13 (cur | prev) . . (+849) . . Jwarner (talk | contribs) | ||
| 20:10 (cur | prev) . . (+2,725) . . Alikhaki (talk | contribs) (→Relapsed or refractory, non-randomized or retrospective data: Added duvelisib for relapsed/refractory disease (DYNAMO study)) (Tag: Visual edit) |
| m 22:01 | MediaWiki:Sitenotice (diff | hist) . . (-601) . . Dryang (talk | contribs) (Blood article notice no longer needed) |
| m 19:58 | Prostate cancer (3 changes | history) . . (+5,460) . . [Jwarner (3×)] | ||
| m | 19:58 (cur | prev) . . (+14) . . Jwarner (talk | contribs) | ||
| m | 19:56 (cur | prev) . . (+4,094) . . Jwarner (talk | contribs) | ||
| m | 15:44 (cur | prev) . . (+1,352) . . Jwarner (talk | contribs) (→Cabazitaxel & Prednisone {{#subobject:23 |Regimen=1}}) |
| m 19:45 | Esophageal cancer (diff | hist) . . (+8) . . Jwarner (talk | contribs) (→Fluorouracil, Paclitaxel, RT {{#subobject:52e768|Regimen=1}}) |
| m 16:58 | Prostate cancer - historical (diff | hist) . . (-12) . . Jwarner (talk | contribs) (→Castration) |
| m 16:53 | Ontology (diff | hist) . . (+13) . . Jwarner (talk | contribs) |
20 January 2020
| m 21:46 | Hepatocellular carcinoma (2 changes | history) . . (+1,986) . . [Jwarner (2×)] | ||
| m | 21:46 (cur | prev) . . (+501) . . Jwarner (talk | contribs) | ||
| m | 21:38 (cur | prev) . . (+1,485) . . Jwarner (talk | contribs) (→First-line therapy for advanced or metastatic disease) |
| m 21:14 | T-cell prolymphocytic leukemia (diff | hist) . . (-23) . . Jwarner (talk | contribs) |
18 January 2020
| m 22:26 | Ovarian cancer (diff | hist) . . (+2,765) . . Jwarner (talk | contribs) |
| m 21:54 | Renal cell carcinoma (2 changes | history) . . (+3,631) . . [Jwarner (2×)] | ||
| m | 21:54 (cur | prev) . . (+26) . . Jwarner (talk | contribs) (→Regimen {{#subobject:9d436d|Variant=1}}) | ||
| m | 21:52 (cur | prev) . . (+3,605) . . Jwarner (talk | contribs) |
| m 21:09 | Editing test page (diff | hist) . . (+729) . . Jwarner (talk | contribs) (→BEACOPP 4+4) |
| m 17:52 | Multiple myeloma, relapsed-refractory (diff | hist) . . (+1,620) . . Jwarner (talk | contribs) |
17 January 2020
| 21:47 | Non-small cell lung cancer, EGFR-mutated (2 changes | history) . . (+4,648) . . [Jwarner (2×)] | ||
| m | 21:47 (cur | prev) . . (+2,169) . . Jwarner (talk | contribs) (→Advanced or metastatic disease, EGFR inhibitor-naive) | ||
| 21:40 (cur | prev) . . (+2,479) . . Jwarner (talk | contribs) (→Gefitinib monotherapy {{#subobject:fb3998|Regimen=1}}) |
| 14:01 | Esophageal cancer (6 changes | history) . . (+1,891) . . [Jwarner (6×)] | ||
| m | 14:01 (cur | prev) . . (+154) . . Jwarner (talk | contribs) (→Definitive therapy) | ||
| m | 13:58 (cur | prev) . . (-28) . . Jwarner (talk | contribs) (→Fluorouracil & Paclitaxel {{#subobject:58ub68|Regimen=1}}) | ||
| 13:58 (cur | prev) . . (+1,818) . . Jwarner (talk | contribs) (→Consolidation after definitive therapy) | |||
| m | 13:54 (cur | prev) . . (+88) . . Jwarner (talk | contribs) (→Fluorouracil, Paclitaxel, RT {{#subobject:52e768|Regimen=1}}) | ||
| m | 13:53 (cur | prev) . . (-152) . . Jwarner (talk | contribs) (→Fluorouracil, Paclitaxel, RT {{#subobject:52e768|Regimen=1}}) | ||
| m | 13:48 (cur | prev) . . (+11) . . Jwarner (talk | contribs) (→Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}}) |
